Assistant professor
Université de Montréal
Université de Montréal
laval , Quebec, Canada
Nadine Taleb, MD, PhD
Nadine Taleb is an endocrinologist at the Centre Hospitalier de l’Université de Montréal (CHUM) and at the clinic of the Montreal Clinical Research Institute (IRCM), director of the clinic for young adults living with diabetes at the Centre d’Expertise de Diabète at the CHUM (JA-CED). She is assistant clinical professor at the University of Montreal and clinical researcher, cardiometabolic axis of the Research Center CR-CHUM and a FRQS scholar (FRQS Fonds de recherche du Québec - Santé). She has participated in and published several studies on the management of type 1 diabetes, particularly the prevention and treatment of hypoglycemia using technology. Her current research program addresses the issue of heterogeneity in diabetes; including atypical diabetes phenotypes and autoimmune diabetes in adults, sometimes referred to as LADA. This program seeks to better classify autoimmune diabetes subtypes, improve screening strategies; understand the respective risks of developing acute and chronic complications, explore personalized management strategies and preserve beta cell function for as long as possible.
Disclosure(s): Dexcom: Speaker/Honoraria (Terminated, July 1, 2024); Novo Nordisk: Speaker/Honoraria (Terminated, July 20, 2025); Sanofi: Speaker/Honoraria (Terminated, July 20, 2025)
DCS9 - Emerging Adjuvant Therapies in Type 1 Diabetes (& LADA)
Thursday, November 27, 2025
14:30 - 15:45 Toronto